|
|
reverse cholesterol transport
|
GO:0043691 |
6 |
1.000
|
|
|
|
regulation of sterol transport
|
GO:0032371 |
17 |
0.999
|
|
|
|
positive regulation of sterol transport
|
GO:0032373 |
9 |
0.999
|
|
|
|
protein lipid complex subunit organization
|
GO:0071825 |
12 |
0.999
|
Human |
|
|
cholesterol homeostasis
|
GO:0042632 |
44 |
0.997
|
Human |
|
|
phospholipid transport
|
GO:0015914 |
21 |
0.996
|
|
|
|
sterol homeostasis
|
GO:0055092 |
45 |
0.996
|
Human |
|
|
lipid homeostasis
|
GO:0055088 |
63 |
0.996
|
Human Mouse |
|
|
sterol metabolic process
|
GO:0016125 |
58 |
0.995
|
|
|
|
sterol transport
|
GO:0015918 |
38 |
0.995
|
|
|
|
plasma lipoprotein particle remodeling
|
GO:0034369 |
6 |
0.994
|
|
|
|
intracellular cholesterol transport
|
GO:0032367 |
3 |
0.994
|
Human |
|
|
cholesterol transport
|
GO:0030301 |
38 |
0.991
|
|
|
|
organophosphate ester transport
|
GO:0015748 |
28 |
0.989
|
|
|
|
regulation of cholesterol transport
|
GO:0032374 |
17 |
0.988
|
|
|
|
cholesterol efflux
|
GO:0033344 |
24 |
0.988
|
|
|
|
plasma lipoprotein particle organization
|
GO:0071827 |
11 |
0.981
|
Human |
|
|
positive regulation of cholesterol transport
|
GO:0032376 |
9 |
0.981
|
|
|
|
regulation of plasma lipoprotein particle levels
|
GO:0097006 |
23 |
0.972
|
Human |
|
|
cholesterol metabolic process
|
GO:0008203 |
56 |
0.963
|
|
|
|
organic anion transport
|
GO:0015711 |
137 |
0.960
|
|
|
|
negative regulation of sterol transport
|
GO:0032372 |
4 |
0.936
|
|
|
|
phospholipid efflux
|
GO:0033700 |
3 |
0.934
|
|
|
|
organic hydroxy compound transport
|
GO:0015850 |
93 |
0.934
|
|
|
|
intracellular sterol transport
|
GO:0032366 |
3 |
0.922
|
Human |
|
|
negative regulation of cholesterol transport
|
GO:0032375 |
4 |
0.907
|
|
|
|
intracellular lipid transport
|
GO:0032365 |
3 |
0.902
|
Human |
|
|
positive regulation of lipid transport
|
GO:0032370 |
22 |
0.898
|
|
|
|
regulation of lipid transport
|
GO:0032368 |
36 |
0.896
|
|
|
|
cholesterol esterification
|
GO:0034435 |
3 |
0.882
|
|
|
|
negative regulation of lipid transport
|
GO:0032369 |
8 |
0.868
|
|
|
|
regulation of cholesterol metabolic process
|
GO:0090181 |
14 |
0.864
|
|
|
|
positive regulation of cholesterol efflux
|
GO:0010875 |
9 |
0.858
|
|
|
|
regulation of cholesterol biosynthetic process
|
GO:0045540 |
8 |
0.857
|
|
|
|
lipid localization
|
GO:0010876 |
126 |
0.846
|
|
|
|
high density lipoprotein particle remodeling
|
GO:0034375 |
4 |
0.843
|
|
|
|
lipid transport
|
GO:0006869 |
98 |
0.839
|
|
|
|
anion transport
|
GO:0006820 |
177 |
0.834
|
|
|
|
plasma lipoprotein particle clearance
|
GO:0034381 |
13 |
0.825
|
|
|
|
amine metabolic process
|
GO:0009308 |
45 |
0.816
|
|
|
|
positive regulation of lipid biosynthetic process
|
GO:0046889 |
18 |
0.813
|
|
|
|
sterol esterification
|
GO:0034434 |
3 |
0.806
|
|
|
|
steroid metabolic process
|
GO:0008202 |
119 |
0.803
|
|
|
|
regulation of cholesterol efflux
|
GO:0010874 |
13 |
0.713
|
|
|
|
alcohol metabolic process
|
GO:0006066 |
116 |
0.696
|
|
|
|
macromolecular complex remodeling
|
GO:0034367 |
6 |
0.690
|
|
|
|
positive regulation of lipid metabolic process
|
GO:0045834 |
40 |
0.682
|
|
|
|
cholesterol biosynthetic process
|
GO:0006695 |
15 |
0.638
|
|
|
|
lipid biosynthetic process
|
GO:0008610 |
179 |
0.637
|
|
|
|
steroid esterification
|
GO:0034433 |
3 |
0.636
|
|
|
|
negative regulation of immune system process
|
GO:0002683 |
209 |
0.607
|
|
|
|
regulation of lipid metabolic process
|
GO:0019216 |
118 |
0.600
|
|
|
|
regulation of defense response
|
GO:0031347 |
233 |
0.593
|
|
|
|
triglyceride metabolic process
|
GO:0006641 |
51 |
0.591
|
|
|
|
organic hydroxy compound metabolic process
|
GO:1901615 |
203 |
0.564
|
|
|
|
regulation of beta amyloid clearance
|
GO:1900221 |
1 |
0.562
|
Mouse |
|
|
cytokine production
|
GO:0001816 |
319 |
0.561
|
Human |
|
|
regulation of cellular catabolic process
|
GO:0031329 |
242 |
0.551
|
|
|
|
glycerolipid metabolic process
|
GO:0046486 |
122 |
0.530
|
|
|
|
regulation of response to wounding
|
GO:1903034 |
189 |
0.526
|
|
|
|
innate immune response
|
GO:0045087 |
157 |
0.521
|
|
|
|
anion homeostasis
|
GO:0055081 |
16 |
0.511
|
Human |
|
|
adaptive immune response
|
GO:0002250 |
155 |
0.494
|
|
|
|
glucocorticoid metabolic process
|
GO:0008211 |
9 |
0.483
|
|
|
|
regulation of planar cell polarity pathway involved in ventricular septum morphogenesis
|
GO:2000148 |
1 |
0.479
|
|
|
|
intestinal cholesterol absorption
|
GO:0030299 |
5 |
0.465
|
|
|
|
regulation of cellular ketone metabolic process
|
GO:0010565 |
66 |
0.463
|
|
|
|
glycerophospholipid metabolic process
|
GO:0006650 |
71 |
0.460
|
|
|
|
low density lipoprotein particle remodeling
|
GO:0034374 |
2 |
0.458
|
|
|
|
sterol biosynthetic process
|
GO:0016126 |
17 |
0.450
|
|
|
|
response to low density lipoprotein particle
|
GO:0055098 |
2 |
0.443
|
Human |
|
|
activation of immune response
|
GO:0002253 |
138 |
0.441
|
|
|
|
defense response to other organism
|
GO:0098542 |
197 |
0.441
|
|
|
|
response to lipopolysaccharide
|
GO:0032496 |
128 |
0.441
|
|
|
|
positive regulation of presynaptic membrane organization
|
GO:1901631 |
1 |
0.439
|
|
|
|
phospholipid homeostasis
|
GO:0055091 |
6 |
0.437
|
Human |
|
|
regulation of adaptive immune response
|
GO:0002819 |
90 |
0.419
|
|
|
|
negative regulation of cell proliferation
|
GO:0008285 |
296 |
0.385
|
|
|
|
cellular amino acid metabolic process
|
GO:0006520 |
103 |
0.368
|
|
|
|
phospholipid metabolic process
|
GO:0006644 |
87 |
0.367
|
|
|
|
blood vessel morphogenesis
|
GO:0048514 |
285 |
0.366
|
|
|
|
cellular lipid metabolic process
|
GO:0044255 |
323 |
0.366
|
|
|
|
neutral lipid metabolic process
|
GO:0006638 |
57 |
0.363
|
|
|
|
cellular response to molecule of bacterial origin
|
GO:0071219 |
83 |
0.357
|
|
|
|
protein lipid complex remodeling
|
GO:0034368 |
6 |
0.356
|
|
|
|
negative regulation of cell activation
|
GO:0050866 |
111 |
0.348
|
|
|
|
regulation of inflammatory response
|
GO:0050727 |
147 |
0.347
|
|
|
|
lipid modification
|
GO:0030258 |
65 |
0.345
|
|
|
|
alcohol catabolic process
|
GO:0046164 |
16 |
0.332
|
|
|
|
epithelial cell proliferation
|
GO:0050673 |
174 |
0.330
|
|
|
|
mapk cascade
|
GO:0000165 |
281 |
0.320
|
Mouse |
|
|
inflammatory response
|
GO:0006954 |
244 |
0.316
|
|
|
|
high density lipoprotein particle assembly
|
GO:0034380 |
3 |
0.316
|
Human |
|
|
regulation of protein kinase activity
|
GO:0045859 |
232 |
0.313
|
|
|
|
carbohydrate metabolic process
|
GO:0005975 |
230 |
0.310
|
|
|
|
peptidyl tyrosine phosphorylation
|
GO:0018108 |
143 |
0.307
|
|
|
|
lipid catabolic process
|
GO:0016042 |
69 |
0.304
|
|
|
|
cation homeostasis
|
GO:0055080 |
212 |
0.302
|
|
|
|
production of molecular mediator of immune response
|
GO:0002440 |
103 |
0.301
|
|
|
|
formation of radial glial scaffolds
|
GO:0021943 |
4 |
0.297
|
|
|
|
carbohydrate derivative biosynthetic process
|
GO:1901137 |
183 |
0.287
|
Human Mouse |
|
|
regulation of phospholipid efflux
|
GO:1902994 |
2 |
0.284
|
Mouse |
|
|
macromolecule catabolic process
|
GO:0009057 |
281 |
0.281
|
|
|
|
cellular ketone metabolic process
|
GO:0042180 |
84 |
0.279
|
|
|
|
protein catabolic process
|
GO:0030163 |
221 |
0.278
|
|
|
|
regulation of lymphocyte activation
|
GO:0051249 |
240 |
0.272
|
|
|
|
negative regulation of lipid storage
|
GO:0010888 |
6 |
0.269
|
|
|
|
cytokine mediated signaling pathway
|
GO:0019221 |
115 |
0.267
|
|
|
|
t cell activation
|
GO:0042110 |
289 |
0.267
|
|
|
|
adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains
|
GO:0002460 |
145 |
0.265
|
|
|
|
regulation of kinase activity
|
GO:0043549 |
249 |
0.264
|
|
|
|
positive regulation of steroid metabolic process
|
GO:0045940 |
5 |
0.258
|
|
|
|
positive regulation of innate immune response
|
GO:0045089 |
80 |
0.255
|
|
|
|
cellular amine metabolic process
|
GO:0044106 |
44 |
0.255
|
|
|
|
regulation of cellular amino acid metabolic process
|
GO:0006521 |
5 |
0.252
|
|
|
|
regulation of transferase activity
|
GO:0051338 |
263 |
0.247
|
|
|
|
steroid biosynthetic process
|
GO:0006694 |
47 |
0.246
|
|
|
|
acylglycerol metabolic process
|
GO:0006639 |
55 |
0.244
|
|
|
|
regulation of leukocyte mediated immunity
|
GO:0002703 |
104 |
0.237
|
|
|
|
purine nucleotide metabolic process
|
GO:0006163 |
302 |
0.237
|
Human Mouse |
|
|
regulation of intestinal cholesterol absorption
|
GO:0030300 |
4 |
0.234
|
|
|
|
regulation of t cell activation
|
GO:0050863 |
170 |
0.233
|
|
|
|
small molecule biosynthetic process
|
GO:0044283 |
132 |
0.232
|
|
|
|
sterol transmembrane transport
|
GO:0035382 |
2 |
0.229
|
|
|
|
nucleoside phosphate metabolic process
|
GO:0006753 |
338 |
0.229
|
Human Mouse |
|
|
regulation of phospholipase a2 activity
|
GO:0032429 |
3 |
0.225
|
|
|
|
positive regulation of transferase activity
|
GO:0051347 |
167 |
0.225
|
|
|
|
regulation of cellular response to stress
|
GO:0080135 |
159 |
0.223
|
|
|
|
acylglycerol homeostasis
|
GO:0055090 |
16 |
0.223
|
|
|
|
protein modification by small protein conjugation or removal
|
GO:0070647 |
207 |
0.221
|
|
|
|
regulation of cell activation
|
GO:0050865 |
289 |
0.215
|
|
|
|
urogenital system development
|
GO:0001655 |
261 |
0.214
|
|
|
|
cell substrate adhesion
|
GO:0031589 |
130 |
0.212
|
|
|
|
negative regulation of cellular amide metabolic process
|
GO:0034249 |
4 |
0.212
|
Mouse |
|
|
response to organic cyclic compound
|
GO:0014070 |
198 |
0.211
|
|
|
|
negative regulation of defense response
|
GO:0031348 |
77 |
0.211
|
|
|
|
cellular biogenic amine metabolic process
|
GO:0006576 |
28 |
0.210
|
|
|
|
transmembrane receptor protein tyrosine kinase signaling pathway
|
GO:0007169 |
247 |
0.209
|
|
|
|
cellular macromolecule catabolic process
|
GO:0044265 |
206 |
0.208
|
|
|
|
negative regulation of planar cell polarity pathway involved in pericardium morphogenesis
|
GO:2000166 |
1 |
0.207
|
|
|
|
regulation of cytokine production
|
GO:0001817 |
266 |
0.206
|
|
|
|
nucleotide metabolic process
|
GO:0009117 |
332 |
0.205
|
Human Mouse |
|
|
intestinal absorption
|
GO:0050892 |
13 |
0.204
|
|
|
|
positive regulation of lymphocyte activation
|
GO:0051251 |
140 |
0.201
|
|
|
|
low density lipoprotein particle clearance
|
GO:0034383 |
8 |
0.199
|
|
|
|
positive regulation of protein phosphorylation
|
GO:0001934 |
242 |
0.199
|
|
|
|
cell activation involved in immune response
|
GO:0002263 |
126 |
0.193
|
|
|
|
protein processing
|
GO:0016485 |
163 |
0.192
|
|
|
|
regulation of lipid storage
|
GO:0010883 |
20 |
0.191
|
|
|
|
protein glycosylation
|
GO:0006486 |
55 |
0.190
|
|
|
|
glycerolipid biosynthetic process
|
GO:0045017 |
50 |
0.187
|
|
|
|
triglyceride biosynthetic process
|
GO:0019432 |
17 |
0.186
|
|
|
|
alcohol biosynthetic process
|
GO:0046165 |
43 |
0.184
|
|
|
|
proteolysis involved in cellular protein catabolic process
|
GO:0051603 |
147 |
0.184
|
|
|
|
lymphocyte differentiation
|
GO:0030098 |
242 |
0.183
|
|
|
|
g protein coupled receptor signaling pathway
|
GO:0007186 |
243 |
0.183
|
Human |
|
|
spermatid differentiation
|
GO:0048515 |
115 |
0.182
|
|
|
|
spermatid development
|
GO:0007286 |
108 |
0.179
|
|
|
|
morphogenesis of a branching epithelium
|
GO:0061138 |
193 |
0.179
|
|
|
|
angiogenesis
|
GO:0001525 |
201 |
0.176
|
|
|
|
lipoprotein biosynthetic process
|
GO:0042158 |
33 |
0.174
|
|
|
|
ribonucleotide metabolic process
|
GO:0009259 |
291 |
0.174
|
Human Mouse |
|
|
regulation of phospholipid transport
|
GO:2001138 |
4 |
0.173
|
Mouse |
|
|
protein modification by small protein conjugation
|
GO:0032446 |
187 |
0.173
|
|
|
|
negative regulation of planar cell polarity pathway involved in cardiac right atrium morphogenesis
|
GO:2000162 |
1 |
0.170
|
|
|
|
small molecule catabolic process
|
GO:0044282 |
71 |
0.170
|
|
|
|
positive regulation of dendrite development
|
GO:1900006 |
21 |
0.169
|
|
|
|
regulation of body fluid levels
|
GO:0050878 |
162 |
0.168
|
Mouse |
|
|
cellular protein catabolic process
|
GO:0044257 |
155 |
0.168
|
|
|
|
regulation of proteolysis
|
GO:0030162 |
164 |
0.165
|
|
|
|
cdc42 protein signal transduction
|
GO:0032488 |
0 |
0.164
|
Human |
|
|
canonical wnt signaling pathway involved in heart development
|
GO:0061316 |
3 |
0.164
|
|
|
|
canonical wnt signaling pathway involved in positive regulation of cardiac outflow tract cell proliferation
|
GO:0061324 |
2 |
0.163
|
|
|
|
positive regulation of cytokine production
|
GO:0001819 |
174 |
0.162
|
|
|
|
peptidyl amino acid modification
|
GO:0018193 |
336 |
0.162
|
|
|
|
cellularization
|
GO:0007349 |
1 |
0.162
|
|
|
|
extrinsic apoptotic signaling pathway
|
GO:0097191 |
126 |
0.159
|
|
|
|
glycosylation
|
GO:0070085 |
62 |
0.158
|
|
|
|
glial cell differentiation
|
GO:0010001 |
131 |
0.158
|
|
|
|
posttranscriptional regulation of gene expression
|
GO:0010608 |
155 |
0.157
|
|
|
|
toxin transport
|
GO:1901998 |
38 |
0.157
|
|
|
|
maintenance of location
|
GO:0051235 |
89 |
0.156
|
|
|
|
response to nutrient levels
|
GO:0031667 |
109 |
0.156
|
|
|
|
leukocyte activation involved in immune response
|
GO:0002366 |
126 |
0.156
|
|
|
|
regulation of reactive oxygen species metabolic process
|
GO:2000377 |
40 |
0.155
|
|
|
|
regulation of phosphatidylcholine catabolic process
|
GO:0010899 |
2 |
0.155
|
|
|
|
nucleobase containing small molecule metabolic process
|
GO:0055086 |
352 |
0.155
|
Human Mouse |
|
|
organic hydroxy compound biosynthetic process
|
GO:1901617 |
77 |
0.155
|
|
|
|
immune effector process
|
GO:0002252 |
321 |
0.154
|
|
|
|
regulation of cellular protein catabolic process
|
GO:1903362 |
61 |
0.153
|
|
|
|
regulation of secretion by cell
|
GO:1903530 |
249 |
0.152
|
|
|
|
regulation of mapk cascade
|
GO:0043408 |
248 |
0.152
|
Mouse |
|
|
cellular response to cytokine stimulus
|
GO:0071345 |
189 |
0.150
|
|
|
|
positive regulation of nervous system development
|
GO:0051962 |
221 |
0.150
|
|
|
|
negative regulation of inflammatory response
|
GO:0050728 |
61 |
0.150
|
|
|
|
regulation of planar cell polarity pathway involved in outflow tract morphogenesis
|
GO:2000163 |
1 |
0.148
|
|
|
|
macromolecule glycosylation
|
GO:0043413 |
55 |
0.148
|
|
|
|
negative regulation of protein metabolic process
|
GO:0051248 |
282 |
0.146
|
Mouse |
|
|
cellular chemical homeostasis
|
GO:0055082 |
215 |
0.146
|
|
|
|
immune response activating signal transduction
|
GO:0002757 |
116 |
0.146
|
|
|
|
regulation of cell migration
|
GO:0030334 |
219 |
0.145
|
|
|
|
cholesterol catabolic process
|
GO:0006707 |
5 |
0.145
|
|
|
|
ion transmembrane transport
|
GO:0034220 |
361 |
0.145
|
|
|
|
protein ubiquitination
|
GO:0016567 |
171 |
0.142
|
|
|
|
chemotaxis
|
GO:0006935 |
247 |
0.141
|
|
|
|
connective tissue development
|
GO:0061448 |
179 |
0.140
|
|
|
|
defense response to bacterium
|
GO:0042742 |
119 |
0.140
|
|
|
|
male gamete generation
|
GO:0048232 |
285 |
0.138
|
|
|
|
negative regulation of platelet derived growth factor receptor beta signaling pathway
|
GO:2000587 |
2 |
0.137
|
|
|
|
gland development
|
GO:0048732 |
330 |
0.136
|
|
|
|
positive regulation of defense response
|
GO:0031349 |
124 |
0.135
|
|
|
|
neuron death
|
GO:0070997 |
154 |
0.135
|
|
|
|
transmembrane transport
|
GO:0055085 |
412 |
0.133
|
|
|
|
regulation of cellular amine metabolic process
|
GO:0033238 |
20 |
0.133
|
|
|
|
regulation of cholesterol esterification
|
GO:0010872 |
2 |
0.133
|
|
|
|
negative regulation of cellular component organization
|
GO:0051129 |
194 |
0.132
|
|
|
|
regulation of digestive system process
|
GO:0044058 |
13 |
0.132
|
|
|
|
positive regulation of cellular protein catabolic process
|
GO:1903364 |
34 |
0.132
|
|
|
|
peptidyl tyrosine modification
|
GO:0018212 |
145 |
0.131
|
|
|
|
skin development
|
GO:0043588 |
220 |
0.130
|
Mouse |
|
|
regulation of steroid biosynthetic process
|
GO:0050810 |
26 |
0.129
|
|
|
|
leukocyte migration
|
GO:0050900 |
124 |
0.129
|
|
|
|
regulation of membrane protein ectodomain proteolysis
|
GO:0051043 |
3 |
0.129
|
|
|
|
negative regulation of epithelial cell proliferation
|
GO:0050680 |
64 |
0.129
|
|
|
|
ribose phosphate metabolic process
|
GO:0019693 |
291 |
0.128
|
Human Mouse |
|
|
lipoprotein metabolic process
|
GO:0042157 |
43 |
0.128
|
|
|
|
negative regulation of cellular protein metabolic process
|
GO:0032269 |
247 |
0.128
|
|
|
|
immune response regulating signaling pathway
|
GO:0002764 |
125 |
0.128
|
|
|
|
kidney development
|
GO:0001822 |
213 |
0.128
|
|
|
|
lipid storage
|
GO:0019915 |
36 |
0.127
|
|
|
|
ribonucleoside triphosphate catabolic process
|
GO:0009203 |
199 |
0.126
|
Mouse |
|
|
cellular calcium ion homeostasis
|
GO:0006874 |
119 |
0.126
|
|
|
|
regulation of neuron differentiation
|
GO:0045664 |
281 |
0.125
|
|
|
|
cellular response to lipid
|
GO:0071396 |
145 |
0.124
|
|
|
|
stem cell maintenance
|
GO:0019827 |
130 |
0.124
|
|
|
|
positive regulation of programmed cell death
|
GO:0043068 |
218 |
0.124
|
|
|
|
modification dependent macromolecule catabolic process
|
GO:0043632 |
133 |
0.123
|
|
|
|
membrane organization
|
GO:0061024 |
245 |
0.121
|
|
|
|
positive regulation of steroid biosynthetic process
|
GO:0010893 |
4 |
0.120
|
|
|
|
cytokine production involved in immune response
|
GO:0002367 |
34 |
0.120
|
|
|
|
regulation of removal of superoxide radicals
|
GO:2000121 |
4 |
0.119
|
|
|
|
regulation of adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains
|
GO:0002822 |
87 |
0.119
|
|
|
|
regulation of map kinase activity
|
GO:0043405 |
120 |
0.118
|
|
|
|
monocarboxylic acid metabolic process
|
GO:0032787 |
191 |
0.118
|
|
|
|
organic cyclic compound catabolic process
|
GO:1901361 |
295 |
0.117
|
Mouse |
|
|
positive regulation of cellular catabolic process
|
GO:0031331 |
148 |
0.116
|
|
|
|
hindbrain development
|
GO:0030902 |
128 |
0.116
|
|
|
|
negative regulation of planar cell polarity pathway involved in ventricular septum morphogenesis
|
GO:2000149 |
1 |
0.115
|
|
|
|
response to oxidative stress
|
GO:0006979 |
123 |
0.114
|
|
|
|
neutral lipid biosynthetic process
|
GO:0046460 |
18 |
0.114
|
|
|
|
cellular response to hormone stimulus
|
GO:0032870 |
150 |
0.114
|
|
|
|
positive regulation of reactive oxygen species metabolic process
|
GO:2000379 |
11 |
0.113
|
|
|
|
purine ribonucleoside triphosphate catabolic process
|
GO:0009207 |
199 |
0.112
|
Mouse |
|
|
positive regulation of cell activation
|
GO:0050867 |
158 |
0.112
|
|
|
|
positive regulation of apoptotic process
|
GO:0043065 |
217 |
0.112
|
|
|
|
modification dependent protein catabolic process
|
GO:0019941 |
133 |
0.111
|
|
|
|
apoptotic signaling pathway
|
GO:0097190 |
306 |
0.111
|
|
|
|
regulation of endocytosis
|
GO:0030100 |
69 |
0.110
|
Mouse |
|
|
positive regulation of protein catabolic process
|
GO:0045732 |
60 |
0.108
|
|
|
|
positive regulation of protein kinase b signaling
|
GO:0051897 |
32 |
0.108
|
|
|
|
negative regulation of apoptotic signaling pathway
|
GO:2001234 |
104 |
0.107
|
|
|
|
nucleoside monophosphate metabolic process
|
GO:0009123 |
85 |
0.107
|
Mouse |
|
|
sterol catabolic process
|
GO:0016127 |
5 |
0.107
|
|
|
|
negative regulation of response to wounding
|
GO:1903035 |
77 |
0.106
|
|
|
|
beta amyloid formation
|
GO:0034205 |
9 |
0.106
|
Mouse |
|
|
positive regulation of mapk cascade
|
GO:0043410 |
170 |
0.105
|
Mouse |
|
|
coagulation
|
GO:0050817 |
78 |
0.104
|
|
|
|
plasma lipoprotein particle assembly
|
GO:0034377 |
6 |
0.104
|
Human |
|
|
b cell activation
|
GO:0042113 |
161 |
0.104
|
|
|
|
calcium ion homeostasis
|
GO:0055074 |
127 |
0.104
|
|
|
|
reactive oxygen species biosynthetic process
|
GO:1903409 |
8 |
0.104
|
|
|
|
erythrocyte differentiation
|
GO:0030218 |
88 |
0.103
|
|
|
|
negative regulation of cytokine production
|
GO:0001818 |
84 |
0.102
|
|
|
|
immune response activating cell surface receptor signaling pathway
|
GO:0002429 |
72 |
0.101
|
|
|
|
organic hydroxy compound catabolic process
|
GO:1901616 |
25 |
0.101
|
|
|
|
positive regulation of ion transport
|
GO:0043270 |
65 |
0.101
|
Mouse |
|
|
positive regulation of adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains
|
GO:0002824 |
61 |
0.101
|
|
|
|
positive regulation of lipid storage
|
GO:0010884 |
10 |
0.100
|
|
|
|
regulation of lipid biosynthetic process
|
GO:0046890 |
54 |
0.100
|
|
|
|
muscle tissue development
|
GO:0060537 |
308 |
0.100
|
|
|
|
axonogenesis
|
GO:0007409 |
274 |
0.100
|
|
|
|
glycoprotein biosynthetic process
|
GO:0009101 |
89 |
0.099
|
Mouse |
|
|
neuron apoptotic process
|
GO:0051402 |
142 |
0.099
|
|
|
|
appendage development
|
GO:0048736 |
166 |
0.099
|
|
|
|
regulation of hormone levels
|
GO:0010817 |
211 |
0.098
|
|
|
|
cellular ion homeostasis
|
GO:0006873 |
165 |
0.098
|
|
|
|
protein localization to membrane
|
GO:0072657 |
108 |
0.098
|
|
|
|
regulation of steroid metabolic process
|
GO:0019218 |
39 |
0.097
|
|
|
|
positive regulation of protein ubiquitination involved in ubiquitin dependent protein catabolic process
|
GO:2000060 |
8 |
0.097
|
|
|
|
positive regulation of cholesterol biosynthetic process
|
GO:0045542 |
3 |
0.096
|
|
|
|
lipid digestion
|
GO:0044241 |
7 |
0.096
|
|
|
|
positive regulation of cell development
|
GO:0010720 |
237 |
0.096
|
|
|
|
cellular response to oxidative stress
|
GO:0034599 |
76 |
0.096
|
|
|
|
ribonucleotide catabolic process
|
GO:0009261 |
208 |
0.095
|
Mouse |
|
|
female sex differentiation
|
GO:0046660 |
84 |
0.095
|
|
|
|
regulation of rho protein signal transduction
|
GO:0035023 |
71 |
0.094
|
Human |
|
|
negative regulation of planar cell polarity pathway involved in outflow tract morphogenesis
|
GO:2000164 |
1 |
0.094
|
|
|
|
lipoprotein catabolic process
|
GO:0042159 |
7 |
0.094
|
|
|
|
regulation of planar cell polarity pathway involved in neural tube closure
|
GO:2000167 |
1 |
0.094
|
|
|
|
positive regulation of peptidyl tyrosine phosphorylation
|
GO:0050731 |
61 |
0.093
|
|
|
|
phagocytosis
|
GO:0006909 |
66 |
0.093
|
|
|
|
cellular divalent inorganic cation homeostasis
|
GO:0072503 |
127 |
0.091
|
|
|
|
spermatogenesis
|
GO:0007283 |
284 |
0.091
|
|
|
|
positive regulation of cellular amine metabolic process
|
GO:0033240 |
5 |
0.091
|
|
|
|
peptide metabolic process
|
GO:0006518 |
46 |
0.091
|
Mouse |
|
|
forebrain development
|
GO:0030900 |
302 |
0.089
|
|
|
|
b cell proliferation
|
GO:0042100 |
53 |
0.089
|
|
|
|
negative regulation of endothelial cell proliferation
|
GO:0001937 |
8 |
0.088
|
|
|
|
regulation of epithelial cell proliferation
|
GO:0050678 |
141 |
0.088
|
|
|
|
respiratory tube development
|
GO:0030323 |
167 |
0.087
|
Mouse |
|
|
digestive tract development
|
GO:0048565 |
190 |
0.087
|
|
|
|
tissue remodeling
|
GO:0048771 |
102 |
0.086
|
|
|
|
positive regulation of protein modification process
|
GO:0031401 |
299 |
0.086
|
|
|
|
positive regulation of t cell activation
|
GO:0050870 |
101 |
0.086
|
|
|
|
cholesterol import
|
GO:0070508 |
2 |
0.085
|
|
|
|
positive regulation of cellular amino acid metabolic process
|
GO:0045764 |
3 |
0.085
|
|
|
|
receptor mediated endocytosis of low density lipoprotein particle involved in cholesterol transport
|
GO:0090118 |
1 |
0.084
|
|
|
|
innate immune response activating signal transduction
|
GO:0002758 |
50 |
0.084
|
|
|
|
response to molecule of bacterial origin
|
GO:0002237 |
143 |
0.084
|
|
|
|
lymphocyte mediated immunity
|
GO:0002449 |
139 |
0.084
|
|
|
|
dendritic spine maintenance
|
GO:0097062 |
4 |
0.084
|
|
|
|
multicellular organismal signaling
|
GO:0035637 |
91 |
0.084
|
|
|
|
negative regulation of blood vessel endothelial cell migration
|
GO:0043537 |
3 |
0.083
|
|
|
|
positive regulation of sequence specific dna binding transcription factor activity
|
GO:0051091 |
68 |
0.083
|
|
|
|
regulation of intrinsic apoptotic signaling pathway
|
GO:2001242 |
61 |
0.083
|
|
|
|
negative regulation of protein phosphorylation
|
GO:0001933 |
126 |
0.083
|
|
|
|
nuclear transport
|
GO:0051169 |
139 |
0.082
|
|
|
|
organic acid transport
|
GO:0015849 |
101 |
0.082
|
|
|
|
regulation of innate immune response
|
GO:0045088 |
91 |
0.081
|
|
|
|
response to steroid hormone
|
GO:0048545 |
56 |
0.081
|
|
|
|
wnt signaling pathway
|
GO:0016055 |
188 |
0.081
|
|
|
|
regulation of multi organism process
|
GO:0043900 |
111 |
0.080
|
|
|
|
regulation of fat cell differentiation
|
GO:0045598 |
81 |
0.080
|
|
|
|
positive regulation of glial cell proliferation
|
GO:0060252 |
4 |
0.080
|
|
|
|
response to peptide hormone
|
GO:0043434 |
127 |
0.080
|
|
|
|
amyloid precursor protein catabolic process
|
GO:0042987 |
10 |
0.080
|
Mouse |
|
|
very low density lipoprotein particle remodeling
|
GO:0034372 |
1 |
0.080
|
|
|
|
defense response to gram positive bacterium
|
GO:0050830 |
50 |
0.079
|
|
|
|
stress activated protein kinase signaling cascade
|
GO:0031098 |
81 |
0.078
|
|
|
|
glucose metabolic process
|
GO:0006006 |
92 |
0.078
|
|
|
|
dendritic spine development
|
GO:0060996 |
30 |
0.078
|
|
|
|
organonitrogen compound biosynthetic process
|
GO:1901566 |
192 |
0.078
|
Human |
|
|
negative regulation of phosphorylation
|
GO:0042326 |
166 |
0.078
|
|
|
|
ribonucleoside metabolic process
|
GO:0009119 |
245 |
0.077
|
Mouse |
|
|
cellular response to lipopolysaccharide
|
GO:0071222 |
77 |
0.077
|
|
|
|
regulation of neuron apoptotic process
|
GO:0043523 |
122 |
0.077
|
|
|
|
negative regulation of neuron death
|
GO:1901215 |
98 |
0.077
|
|
|
|
negative regulation of planar cell polarity pathway involved in heart morphogenesis
|
GO:2000160 |
1 |
0.076
|
|
|
|
regulation of protein processing
|
GO:0070613 |
96 |
0.076
|
|
|
|
positive regulation of protein kinase activity
|
GO:0045860 |
144 |
0.076
|
|
|
|
positive regulation of kinase activity
|
GO:0033674 |
155 |
0.076
|
|
|
|
activation of innate immune response
|
GO:0002218 |
56 |
0.075
|
|
|
|
extracellular structure organization
|
GO:0043062 |
148 |
0.075
|
|
|
|
regulation of b cell activation
|
GO:0050864 |
81 |
0.075
|
|
|
|
regulation of protein serine threonine kinase activity
|
GO:0071900 |
157 |
0.075
|
|
|
|
autophagy
|
GO:0006914 |
45 |
0.075
|
|
|
|
cellular homeostasis
|
GO:0019725 |
240 |
0.075
|
|
|
|
stem cell proliferation
|
GO:0072089 |
117 |
0.075
|
|
|
|
positive regulation of amyloid precursor protein catabolic process
|
GO:1902993 |
4 |
0.074
|
|
|
|
regulation of interleukin 6 production
|
GO:0032675 |
55 |
0.074
|
|
|
|
positive regulation of secretion by cell
|
GO:1903532 |
114 |
0.073
|
|
|
|
t cell proliferation
|
GO:0042098 |
120 |
0.073
|
|
|
|
regulation of non canonical wnt signaling pathway
|
GO:2000050 |
12 |
0.073
|
|
|
|
positive regulation of beta amyloid formation
|
GO:1902004 |
4 |
0.073
|
|
|
|
regulation of triglyceride biosynthetic process
|
GO:0010866 |
10 |
0.072
|
|
|
|
leukocyte proliferation
|
GO:0070661 |
172 |
0.072
|
|
|
|
somatic cell dna recombination
|
GO:0016444 |
51 |
0.072
|
|
|
|
regulation of hydrolase activity
|
GO:0051336 |
246 |
0.072
|
|
|
|
heterocycle catabolic process
|
GO:0046700 |
280 |
0.071
|
Mouse |
|
|
negative regulation of cholesterol efflux
|
GO:0090370 |
4 |
0.071
|
|
|
|
divalent inorganic cation homeostasis
|
GO:0072507 |
138 |
0.071
|
|
|
|
positive regulation of neuron differentiation
|
GO:0045666 |
141 |
0.071
|
|
|
|
regulation of nucleotide metabolic process
|
GO:0006140 |
169 |
0.071
|
Human |
|
|
nucleoside phosphate catabolic process
|
GO:1901292 |
222 |
0.070
|
Mouse |
|
|
protein ubiquitination involved in ubiquitin dependent protein catabolic process
|
GO:0042787 |
25 |
0.070
|
|
|
|
cell adhesion
|
GO:0007155 |
329 |
0.070
|
|
|
|
glycerophospholipid biosynthetic process
|
GO:0046474 |
32 |
0.069
|
|
|
|
regulation of lymphocyte mediated immunity
|
GO:0002706 |
84 |
0.069
|
|
|
|
sperm individualization
|
GO:0007291 |
1 |
0.069
|
|
|
|
regulation of leukocyte proliferation
|
GO:0070663 |
121 |
0.069
|
|
|
|
blood coagulation
|
GO:0007596 |
76 |
0.069
|
|
|
|
excretion
|
GO:0007588 |
22 |
0.068
|
|
|
|
placenta development
|
GO:0001890 |
140 |
0.068
|
|
|
|
multicellular organism growth
|
GO:0035264 |
161 |
0.068
|
|
|
|
renal system development
|
GO:0072001 |
225 |
0.068
|
|
|
|
endocytosis
|
GO:0006897 |
168 |
0.068
|
|
|
|
lymphocyte activation involved in immune response
|
GO:0002285 |
93 |
0.068
|
|
|
|
tissue homeostasis
|
GO:0001894 |
115 |
0.068
|
Mouse |
|
|
ubiquitin dependent protein catabolic process
|
GO:0006511 |
129 |
0.067
|
|
|
|
negative regulation of alcohol biosynthetic process
|
GO:1902931 |
4 |
0.067
|
|
|
|
cell proliferation in hindbrain
|
GO:0021534 |
10 |
0.067
|
|
|
|
positive regulation of protein serine threonine kinase activity
|
GO:0071902 |
106 |
0.067
|
|
|
|
regulation of ras protein signal transduction
|
GO:0046578 |
114 |
0.066
|
Human |
|
|
regulation of blood coagulation
|
GO:0030193 |
28 |
0.065
|
|
|
|
sphingolipid metabolic process
|
GO:0006665 |
45 |
0.065
|
|
|
|
regulation of neurofibrillary tangle assembly
|
GO:1902996 |
1 |
0.065
|
|
|
|
regulation of anatomical structure size
|
GO:0090066 |
178 |
0.065
|
|
|
|
small gtpase mediated signal transduction
|
GO:0007264 |
97 |
0.065
|
Human |
|
|
defense response to gram negative bacterium
|
GO:0050829 |
28 |
0.064
|
|
|
|
liver development
|
GO:0001889 |
66 |
0.064
|
|
|
|
aromatic compound catabolic process
|
GO:0019439 |
286 |
0.064
|
Mouse |
|
|
activation of mapkk activity
|
GO:0000186 |
15 |
0.064
|
|
|
|
organophosphate catabolic process
|
GO:0046434 |
232 |
0.064
|
Mouse |
|
|
regulation of angiogenesis
|
GO:0045765 |
81 |
0.064
|
|
|
|
glycerolipid catabolic process
|
GO:0046503 |
16 |
0.063
|
|
|
|
antigen receptor mediated signaling pathway
|
GO:0050851 |
64 |
0.063
|
|
|
|
planar cell polarity pathway involved in cardiac right atrium morphogenesis
|
GO:0061349 |
2 |
0.063
|
|
|
|
positive regulation of hydrolase activity
|
GO:0051345 |
148 |
0.063
|
|
|
|
negative regulation of protein maturation
|
GO:1903318 |
79 |
0.063
|
|
|
|
positive regulation of protein modification by small protein conjugation or removal
|
GO:1903322 |
30 |
0.063
|
|
|
|
organonitrogen compound catabolic process
|
GO:1901565 |
264 |
0.063
|
Mouse |
|
|
digestive tract morphogenesis
|
GO:0048546 |
147 |
0.063
|
|
|
|
digestion
|
GO:0007586 |
40 |
0.062
|
|
|
|
regulation of tube size
|
GO:0035150 |
57 |
0.062
|
|
|
|
regulation of protein catabolic process
|
GO:0042176 |
108 |
0.061
|
|
|
|
triglyceride rich lipoprotein particle remodeling
|
GO:0034370 |
2 |
0.061
|
|
|
|
neural precursor cell proliferation
|
GO:0061351 |
121 |
0.061
|
|
|
|
negative regulation of nervous system development
|
GO:0051961 |
156 |
0.061
|
|
|
|
somatic stem cell maintenance
|
GO:0035019 |
47 |
0.060
|
|
|
|
negative regulation of extrinsic apoptotic signaling pathway
|
GO:2001237 |
45 |
0.060
|
|
|
|
negative regulation of neuron apoptotic process
|
GO:0043524 |
92 |
0.060
|
|
|
|
immunoglobulin mediated immune response
|
GO:0016064 |
69 |
0.060
|
|
|
|
positive regulation of inflammatory response
|
GO:0050729 |
47 |
0.059
|
|
|
|
glycosyl compound metabolic process
|
GO:1901657 |
246 |
0.059
|
Mouse |
|
|
regulation of extrinsic apoptotic signaling pathway
|
GO:2001236 |
77 |
0.058
|
|
|
|
epidermis development
|
GO:0008544 |
187 |
0.058
|
Mouse |
|
|
alpha amino 3 hydroxy 5 methyl 4 isoxazole propionate selective glutamate receptor clustering
|
GO:0097113 |
3 |
0.058
|
|
|
|
ribonucleoside catabolic process
|
GO:0042454 |
206 |
0.058
|
Mouse |
|
|
protein kinase b signaling
|
GO:0043491 |
74 |
0.058
|
|
|
|
glycoprotein metabolic process
|
GO:0009100 |
116 |
0.058
|
Mouse |
|
|
positive regulation of apoptotic signaling pathway
|
GO:2001235 |
95 |
0.058
|
|
|
|
cellular response to organic cyclic compound
|
GO:0071407 |
87 |
0.058
|
|
|
|
cellular response to external stimulus
|
GO:0071496 |
88 |
0.057
|
|
|
|
positive regulation of adaptive immune response
|
GO:0002821 |
61 |
0.057
|
|
|
|
innate immune response in mucosa
|
GO:0002227 |
3 |
0.057
|
|
|
|
regulation of protein kinase b signaling
|
GO:0051896 |
56 |
0.057
|
|
|
|
regulation of presynaptic membrane organization
|
GO:1901629 |
3 |
0.057
|
|
|
|
cerebellum development
|
GO:0021549 |
77 |
0.056
|
|
|
|
regulation of production of molecular mediator of immune response
|
GO:0002700 |
65 |
0.056
|
|
|
|
regulation of apoptotic signaling pathway
|
GO:2001233 |
197 |
0.056
|
|
|
|
negative regulation of hydrolase activity
|
GO:0051346 |
71 |
0.056
|
|
|
|
organophosphate biosynthetic process
|
GO:0090407 |
122 |
0.056
|
Human |
|
|
cell maturation
|
GO:0048469 |
127 |
0.056
|
|
|
|
heart morphogenesis
|
GO:0003007 |
178 |
0.055
|
|
|
|
low density lipoprotein receptor particle metabolic process
|
GO:0032799 |
4 |
0.055
|
|
|
|
granulocyte chemotaxis
|
GO:0071621 |
39 |
0.055
|
|
|
|
negative regulation of lymphocyte activation
|
GO:0051250 |
91 |
0.055
|
|
|
|
gliogenesis
|
GO:0042063 |
141 |
0.054
|
|
|
|
regulation of phospholipid catabolic process
|
GO:0060696 |
2 |
0.054
|
|
|
|
cellular metal ion homeostasis
|
GO:0006875 |
151 |
0.054
|
|
|
|
axis elongation involved in somitogenesis
|
GO:0090245 |
4 |
0.054
|
|
|
|
regulation of peptidyl tyrosine phosphorylation
|
GO:0050730 |
93 |
0.054
|
|
|
|
lung development
|
GO:0030324 |
164 |
0.053
|
Mouse |
|
|
muscle cell differentiation
|
GO:0042692 |
261 |
0.053
|
|
|
|
interleukin 1 beta production
|
GO:0032611 |
30 |
0.053
|
Human |
|
|
i kappab kinase nf kappab signaling
|
GO:0007249 |
85 |
0.053
|
|
|
|
sterol import
|
GO:0035376 |
2 |
0.053
|
|
|
|
stem cell development
|
GO:0048864 |
219 |
0.053
|
|
|
|
engulfment of apoptotic cell
|
GO:0043652 |
3 |
0.053
|
Mouse |
|
|
regulation of planar cell polarity pathway involved in cardiac right atrium morphogenesis
|
GO:2000161 |
1 |
0.052
|
|
|
|
immune response regulating cell surface receptor signaling pathway
|
GO:0002768 |
80 |
0.052
|
|
|
|
acylglycerol biosynthetic process
|
GO:0046463 |
18 |
0.052
|
|
|
|
cellular response to steroid hormone stimulus
|
GO:0071383 |
33 |
0.052
|
|
|
|
dendrite development
|
GO:0016358 |
115 |
0.052
|
|
|
|
positive regulation of purine nucleotide metabolic process
|
GO:1900544 |
114 |
0.052
|
Human |
|
|
t cell activation involved in immune response
|
GO:0002286 |
43 |
0.051
|
|
|
|
regulation of lymphocyte proliferation
|
GO:0050670 |
117 |
0.051
|
|
|
|
granulocyte migration
|
GO:0097530 |
43 |
0.051
|
|
|
|
regulation of protein modification by small protein conjugation or removal
|
GO:1903320 |
57 |
0.051
|
|
|
|
pattern recognition receptor signaling pathway
|
GO:0002221 |
47 |
0.050
|
|
|
|
regulation of platelet derived growth factor receptor beta signaling pathway
|
GO:2000586 |
2 |
0.050
|
|
|
|
skeletal muscle organ development
|
GO:0060538 |
163 |
0.050
|
|
|
|
cerebral cortex development
|
GO:0021987 |
86 |
0.050
|
|
|
|
carbohydrate derivative catabolic process
|
GO:1901136 |
231 |
0.050
|
Mouse |
|
|
regulation of amyloid precursor protein catabolic process
|
GO:1902991 |
8 |
0.050
|
Mouse |
|
|
cellular response to organonitrogen compound
|
GO:0071417 |
145 |
0.050
|
|